Tobias Deuse, MD

Cardiothoracic Surgeon
Director of Minimally Invasive Cardiac Surgery

Dr. Tobias Deuse is a heart surgeon and director of minimally invasive cardiac surgery at UCSF. He is known for his pioneering work in the development of minimally-invasive techniques for mitral valve repair.


Deuse earned an M.D. from University of Wuerzburg in Germany. He then received advanced training in heart and lung surgery at the University Hospital Munich-Grosshadern and University Heart Center Hamburg-Eppendorf. After obtaining his board certification in Germany as a heart surgeon, Deuse completed a fellowship in lung and heart-lung transplantation at Stanford.

After returning to Germany in 2009, Deuse was appointed director of heart and lung transplantation at the University Heart Center in Hamburg. He achieved international acclaim for his development of innovative approaches to heart failure surgery, most notably minimally-invasive techniques for the implantation of ventricular assist systems. He also demonstrated that high success rates could be achieved in mitral valve repair utilizing robotic-assisted (fully) endoscopic surgery. This minimally invasive procedure, also known as "keyhole surgery," has many benefits for the patient, including substantially reduced post-surgical pain, shorter hospital stays, and a faster recovery and return to daily activities.


Deuse has received numerous honors, including election to the Board of Directors of the International Society for Heart and Lung Transplantation. He is an associate professor of surgery at UCSF.

Read a Q&A with Deuse.


Cardiothoracic Surgery
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-1606
Fax: (415) 353-1312

Hours: Monday to Friday
8 a.m. – 5 p.m.

Lung Transplant Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday 8 a.m. – 5 p.m. (exact times vary depending on number of physicians in clinic)

Mechanical Circulatory Support
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: 8 a.m. – 5 p.m.

More about Tobias Deuse

Additional Languages



Julius Maxmilians Universitaet Wurzburg 2000


University Heart Center Hamburg-Eppendorf, Cardiovascular Surgery 2007


Stanford Hospital, Lung and Heart-Lung Transplantation 2009

Selected Research and Publications

  1. Sanchez JM, Al-Dosari G, Chu S, Beygui R, Deuse T, Badhwar N, Lee RJ. Hybrid and surgical procedures for the treatment of persistent and longstanding persistent atrial fibrillation. Expert Rev Cardiovasc Ther. 2018 Jan 12; 1-7.
  2. Schaefer A, Reichart D, Bernhardt AM, Kubik M, Barten MJ, Wagner FM, Reichenspurner H, Philipp SA, Deuse T. Outcomes of Minimally Invasive Temporary Right Ventricular Assist Device Support for Acute Right Ventricular Failure During Minimally Invasive Left Ventricular Assist Device Implantation. ASAIO J. 2017 Sep/Oct; 63(5):546-550.
  3. Mitsutake Y, Reifart J, Pyun WB, Lyons JK, Deuse T, Schrepfer S, Ikeno F. Differences in Vascular Response between Balloon Overstretch and Stent Overexpansion in Nonatherosclerotic Porcine Coronary Arteries. Comp Med. 2017 Aug 01; 67(4):350-355.
  4. Magnussen C, Bernhardt AM, Ojeda FM, Wagner FM, Gummert J, de By TMMH, Krabatsch T, Mohacsi P, Rybczynski M, Knappe D, Sill B, Deuse T, Blankenberg S, Schnabel RB, Reichenspurner H. Gender differences and outcomes in left ventricular assist device support: The European Registry for Patients with Mechanical Circulatory Support. J Heart Lung Transplant. 2017 Jul 04.
  5. Miller KK, Wang D, Hu X, Hua X, Deuse T, Neofytou E, Renne T, Velden J, Reichenspurner H, Schrepfer S, Bernstein D. Thalidomide treatment prevents chronic graft rejection after aortic transplantation in rats - an experimental study. Transpl Int. 2017 Jul 03.
  6. Bernhardt AM, Pamirsad MA, Brand C, Reichart D, Tienken M, Barten MJ, Schaefer A, Grahn H, Rybczynski M, Deuse T, Reichenspurner H, Wagner FM. The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections. Eur J Cardiothorac Surg. 2017 Jun 01; 51(6):1072-1077.
  7. Eberlein M, Reed RM, Chahla M, Bolukbas S, Blevins A, Van Raemdonck D, Stanzi A, Inci I, Marasco S, Shigemura N, Aigner C, Deuse T. Lobar lung transplantation from deceased donors: A systematic review. World J Transplant. 2017 Feb 24; 7(1):70-80.
  8. Wang D, Tediashvili G, Pecha S, Reichenspurner H, Deuse T, Schrepfer S. Vein Interposition Model: A Suitable Model to Study Bypass Graft Patency. J Vis Exp. 2017 Jan 15; (119).
  9. Guihaire J, Itagaki R, Stubbendorff M, Hua X, Deuse T, Ullrich S, Fadel E, Dorfmller P, Robbins RC, Reichenspurner H, Schumacher U, Schrepfer S. Orthotopic tracheal transplantation using human bronchus: an original xenotransplant model of obliterative airway disorder. Transpl Int. 2016 Dec; 29(12):1337-1348.
  10. Westhofen S, Kugler C, Reichenspurner H, Deuse T. Acute Pulmonary Artery Obstruction as the Primary Manifestation of a Rapidly Growing Intimal Sarcoma in a 54-Year-Old Patient. Thorac Cardiovasc Surg Rep. 2016 Dec; 5(1):36-38.
  11. Westhofen S, Conradi L, Deuse T, Detter C, Vettorazzi E, Treede H, Reichenspurner H. A matched pairs analysis of non-rib-spreading, fully endoscopic, mini-incision technique versus conventional mini-thoracotomy for mitral valve repair. Eur J Cardiothorac Surg. 2016 Dec; 50(6):1181-1187.
  12. Deuse T, Hua X, Stubbendorff M, Spin JM, Neofytou E, Taylor V, Chen Y, Park G, Fink JB, Renne T, Kiefmann M, Kiefmann R, Reichenspurner H, Robbins RC, Schrepfer S. The Selective JAK1/3-Inhibitor R507 Mitigates Obliterative Airway Disease Both With Systemic Administration and Aerosol Inhalation. Transplantation. 2016 May; 100(5):1022-31.
  13. Deuse T, Bara C, Barten MJ, Hirt SW, Doesch AO, Knosalla C, Grinninger C, Stypmann J, Garbade J, Wimmer P, May C, Porstner M, Schulz U. The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation. Contemp Clin Trials. 2015 Nov; 45(Pt B):356-363.
  14. Guihaire J, Deuse T, Wang D, Fadel E, Reichenspurner H, Schrepfer S. Sex Differences in Immunology: More Severe Development of Experimental Pulmonary Hypertension in Male Rats Exposed to Vascular Endothelial Growth Factor Receptor Blockade. Biomed Res Int. 2015; 2015:765292.
  15. Deuse T, Schrepfer S. Distal Airway Stem Cells are Essential for Lung Regeneration. Transplantation. 2015 Aug; 99(8):1540-1.
  16. Wang D, Deuse T, Stubbendorff M, Chernogubova E, Erben RG, Eken SM, Jin H, Li Y, Busch A, Heeger CH, Behnisch B, Reichenspurner H, Robbins RC, Spin JM, Tsao PS, Schrepfer S, Maegdefessel L. Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis. Arterioscler Thromb Vasc Biol. 2015 Sep; 35(9):1945-53.
  17. Neofytou E, Deuse T, Beygui RE, Schrepfer S. Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties. Transplantation. 2015 Jun; 99(6):1113-8.
  18. Conradi L, Schmidt S, Neofytou E, Deuse T, Peters L, Eder A, Hua X, Hansen A, Robbins RC, Beygui RE, Reichenspurner H, Eschenhagen T, Schrepfer S. Immunobiology of fibrin-based engineered heart tissue. Stem Cells Transl Med. 2015 Jun; 4(6):625-31.
  19. Schaefer A, Treede H, Bernhardt A, Wagner FM, Reichenspurner H, Deuse T. Concomitant minimally invasive HVAD and transapical aortic valve implantation. ASAIO J. 2015 Mar-Apr; 61(2):209-12.
  20. Deuse T, Wang D, Stubbendorff M, Itagaki R, Grabosch A, Greaves LC, Alawi M, Grnewald A, Hu X, Hua X, Velden J, Reichenspurner H, Robbins RC, Jaenisch R, Weissman IL, Schrepfer S. SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts. Cell Stem Cell. 2015 Jan 08; 16(1):33-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.